Description
Seeking men and women with hormone receptor positive/ human epidermal growth factor receptor 2-negative (HR+/HER2-) locally advanced inoperable or metastatic breast cancer for a study of an investigational drug combination.
Overview
Participants in this study will be randomly assigned to get either the investigational drug or a placebo (looks like the drug but contains no medicine). All participants will receive the standard chemotherapy for their type of breast cancer.
What we're hoping for
We are studying adding a investigational drug to chemotherapy for metastatic or advanced hormone receptor positive/ human epidermal growth factor receptor 2-negative (HR+/HER2-) locally advanced inoperable or metastatic breast cancer.
Additional Information
ClinicalTrials.gov Identifier: NCT04895358